Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shibata

Showing results (831-840 of 840) with videos related to

Pageof 84
Sort By:
You have reached the last page of results.This site can display upto 840 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell supportR J Morgan, J H Doroshow, K Venkataraman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumorsE M Newman, M Carroll, S A Akman, et al.
Physical Review Letters|November 9, 2016
Transient Weakening of Earth's Magnetic Shield Probed by a Cosmic Ray BurstP K Mohanty, K P Arunbabu, T Aziz, et al.
Immunity|November 9, 2000
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell functionK Shimoda, K Kato, K Aoki, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium TrialR J Morgan, T W Synold, D Gandara, et al.
Cancer Research|July 14, 1998
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysisR J Morgan, E M Newman, J H Doroshow, et al.
Blood|April 27, 1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapyG Somlo, I Sniecinski, A ter Veer, et al.
Gynecologic Oncology|December 22, 1999
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-upR J Morgan, P Braly, G Cecchi, et al.
Physical Review Letters|April 2, 2019
Measurement of the Electrical Properties of a Thundercloud Through Muon Imaging by the GRAPES-3 ExperimentB Hariharan, A Chandra, S R Dugad, et al.
Physical Review Letters|February 16, 2024
Evidence of a Hardening in the Cosmic Ray Proton Spectrum at around 166 TeV Observed by the GRAPES-3 ExperimentF Varsi, S Ahmad, M Chakraborty, et al.
Pageof 84

Showing results (831-840 of 840) with videos related to

Sort By:
Pageof 84
You have reached the last page of results.This site can display upto 840 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell supportR J Morgan, J H Doroshow, K Venkataraman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumorsE M Newman, M Carroll, S A Akman, et al.
Physical Review Letters|November 9, 2016
Transient Weakening of Earth's Magnetic Shield Probed by a Cosmic Ray BurstP K Mohanty, K P Arunbabu, T Aziz, et al.
Immunity|November 9, 2000
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell functionK Shimoda, K Kato, K Aoki, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium TrialR J Morgan, T W Synold, D Gandara, et al.
Cancer Research|July 14, 1998
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysisR J Morgan, E M Newman, J H Doroshow, et al.
Blood|April 27, 1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapyG Somlo, I Sniecinski, A ter Veer, et al.
Gynecologic Oncology|December 22, 1999
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-upR J Morgan, P Braly, G Cecchi, et al.
Physical Review Letters|April 2, 2019
Measurement of the Electrical Properties of a Thundercloud Through Muon Imaging by the GRAPES-3 ExperimentB Hariharan, A Chandra, S R Dugad, et al.
Physical Review Letters|February 16, 2024
Evidence of a Hardening in the Cosmic Ray Proton Spectrum at around 166 TeV Observed by the GRAPES-3 ExperimentF Varsi, S Ahmad, M Chakraborty, et al.
Pageof 84